Home > News & Media > News
Communication starts here.
2013.10
TWi Pharmaceuticals, Inc. Comments on Dexilant® Ruling
2013.7
TWi Pharmaceuticals Receives Patent Allowance for Its Reduced Food Effect Metformin Controlled Release Formulation in United States
2013.06
TWi Biotechnology Announces Completion of Patient Enrollment in Gout Flare Prophylaxis Phase II Trial for AC-201
2013.05
TWi Pharmaceuticals Announces Tentative ANDA Approval for Guanfacine Hydrochloride Extended-Release Tablets

 

Pages:1 - 2 - 3 - 4 - 5 - 6 - 7« Pre · Next »